Location History:
- Shizuoka, JP (2013)
- Sunto-gun, JP (2014)
Company Filing History:
2 out of 59 
2 out of 15 
2 out of 5 
Years Active: 2013-2014
Title: **Inventor Tadashi Ashizawa: Innovating Anticancer Compounds**
Introduction
Tadashi Ashizawa, an accomplished inventor based in Sunto-gun, Japan, has made significant contributions to the field of medicinal chemistry with his innovative inventions. He holds two impactful patents that focus on compounds with potential anticancer properties. Ashizawa's research work highlights his commitment to tackling critical health challenges through inventive solutions.
Latest Patents
Among his notable inventions is a patent for a **1,3,4-Oxadiazole-2-carboxamide compound**. This compound showcases STAT3 inhibitory activity, making it a promising candidate as an anticancer agent. The innovative formula includes a pharmacologically acceptable salt, where Ar represents a furyl group, R may represent a hydrogen atom, and the structure involves a diaryl group such as a biphenyl group.
Additionally, Ashizawa holds a patent for a **STAT3 inhibitor containing a quinolinecarboxamide derivative** as the active ingredient. This patent outlines the derivatives represented by specific molecular formulas where W signifies a bond or an alkylene chain, X can indicate O, S, or NR, and R can include various groups such as hydrogen, halogen, or phenyl.
Career Highlights
Tadashi Ashizawa's career includes significant roles at esteemed organizations, including Pharmadesign, Inc. and Shizuoka Prefecture. His experience in these institutions has provided him with a robust foundation to harness his creativity and scientific understanding while working on groundbreaking innovations in drug development.
Collaborations
Throughout his career, Ashizawa has collaborated with notable colleagues, including Akira Asai and Kenji Matsuno. These collaborations have fostered a creative environment that has propelled his patent work forward and facilitated the exchange of ideas that contribute to advances in medicinal compounds.
Conclusion
Tadashi Ashizawa's dedication to innovation in the field of anticancer agents is commendable. His patents not only exemplify his inventiveness but also his commitment to improving healthcare through science. As he continues to explore new ideas and compounds, it is anticipated that his work will have lasting benefits for cancer treatment and beyond.